Medicine details
| Image |  |
| Name | Metavas MR |
| Dosage | Tablet |
| Generic Name | Trimetazidine Dihydrochloride |
| Classes |
Cardiovascular Agent Vasodilator |
| Diseases |
Angina Cardiovascular Disease Ischemia |
| Company | NIPRO JMI Company Ltd. |
Drug Package Details
| Strength | 35 mg |
| Storage Condition | |
| Origin Country | Bangladesh |
| Commercial Pack | 30 |
| Price per pack | ৳ 150.60 |
| Cost per pack | ৳ 132.53 |
| Package unit | 10 tabs strip |
| Price per unit | ৳ 5.02 |
| Cost per unit | ৳ 4.42 |
| Discount | 0 |
| Coupon | |
| Remarks |
Trimetazidine Dihydrochloride
Trimetazidine dihydrochloride is a metabolic agent that acts as a partial fatty acid oxidation inhibitor. It belongs to the class of anti-ischemic agents.
The usual dose of trimetazidine dihydrochloride is 20 mg three times daily, to be taken orally with or without food.
The most common adverse reactions associated with trimetazidine dihydrochloride include:
- Gastrointestinal disorders: nausea, vomiting, abdominal pain, diarrhea
- Nervous system disorders: dizziness, headache
- Skin and subcutaneous tissue disorders: pruritus, rash
- Trimetazidine dihydrochloride should be used with caution in patients with hepatic or renal impairment.
- Trimetazidine dihydrochloride should not be used in patients with Parkinson's disease or other extrapyramidal disorders.
- Trimetazidine dihydrochloride should be used with caution in patients with a history of depression or psychiatric disorders.
- Patients taking trimetazidine dihydrochloride should be advised not to drive or operate machinery until they know how the drug affects them.
- Trimetazidine dihydrochloride should not be used during pregnancy or lactation.
Contraindication
This drug is contraindicated in patients with hypersensitivity to trimetazidine dihydrochloride or any of the excipients.
None known.
This drug is contraindicated in patients with-
- Parkinson's disease or other extrapyramidal disorders.
- Pregnancy and lactation.
Bangla
English